Group announced a joint venture to co-develop and deliver clinical diagnostic services in China. The new entity will accelerate the development of novel esoteric tests that both organizations will offer in...
Mayo Clinic's Frozen Section Breaks Ground at Simulation Center - Insights
students how to run a code. Mayo Clinic pathology consultant Karen Fritchie, M.D., recently developed a new and innovative way to use the center....
Cross-laboratory collaboration accelerates gold-standard SRA testing - Insights
Utilizing testing capabilities of two separate laboratory facilities, Mayo Clinic Laboratories’ new serotonin release assay (SRA) is a gold-standard test supported by decades of clinical hematopathologic...
Mayo Clinic Laboratory and pathology research roundup: October 3 - Insights
This week's research roundup feature: Gene fusions involving tumor protein p63 gene (TP63) occur in multiple T and B cell lymphomas and portend a dismal prognosis for patients. The function and mechanisms of TP63 fusions remain unclear, and...
Mayo Clinic Laboratory and Pathology Research Roundup: December 26 - Insights
This week's research roundup feature: Histoplasma and Blastomyces antigen detection assays are commonly used diagnostic tools. However, a high level of cross-reactivity between these antigens prevents definitive pathogen identification by...
Mayo Clinic Laboratory and pathology research roundup: September 26 - Insights
This week's research roundup feature: Semaglutide in HFpEF across obesity class and by body weight reduction.
Mayo Clinic Laboratory and pathology research roundup: January 17 - Insights
This week's research roundup features: Exploring gene expression profiles in primary central nervous system vasculitis
Facebook Email or phone Password...
LinkedIn Login, Sign in | LinkedIn
Login to LinkedIn to keep in touch with people you know, share ideas, and build your career.
Research Test Identifies BRCA2 Gene Mutations That Lead to Breast, Ovarian Cancers - Insights
A new test developed by researchers at Mayo Clinic shows which mutations in the BRCA2 gene make women susceptible to developing breast or ovarian cancers. The research behind the test was published today...